Canopy Growth’s Spectrum Therapeutics Completes CBD Clinical Trials SMITHS FALLS, ON, June 5, 2019 /CNW/ - Spectrum Therapeutics ("Spectrum"), the medical division of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (the "Company" or "Canopy Growth") is pleased to share an update on... read more → June 5, 2019 Ryan T.
